WYETH

Members of the Exchange are hereby informed that the trading in equity shares of Wyeth Limited shall be suspended w.e.f. December 10, 2014 (i.e. closing hours of trading on December 9, 2014) on account of Scheme of Amalgamation with Pfizer Limited.

Pfizer Limited has informed the Exchange that the Board of Directors of the Company has fixed December 11, 2014 as the "Record Date" to determine the name of equity shareholders of Wyeth Limited who shall be entitled to receive shares of the Company pursuant to the amalgamation of Wyeth Limited with the Company. As per Clause 6.1 of the Scheme i.e. 7 (seven) equity shares of Rs. 10 (Rupees Ten only) each fully paid up of the Company, will be issued for every 10 (ten) equity shares of Rs.10 (Rupees Ten only) each fully paid up held in Wyeth Limited to the equity shareholders of Wyeth Limited.

Wyeth Limited has informed the Exchange that "Further to our communication dated October 31, 2014 in connection with the approval by the Hon'ble High Court of Judicature at Bombay to the Scheme of Amalgamation between the Company and Pfizer Limited, and their respective shareholders and creditors under the provisions of Sections 391 to 394 of the Companies Act, 1956 ("Scheme"), we wish to inform you that the Scheme has become effective on December 1, 2014 ("Effective Date") after filing of e-Form INC - 28 with the Registrar of Companies / Ministry of Corporate Affairs".

Wyeth Limited has submitted to the Exchange a copy of the minutes of the Annual General Meeting of the Company held on November 10, 2014.

Wyeth Limited has submitted to the Exchange the details of voting results of the Annual General Meeting of the Company held on the November 10, 2014 as per clause 35A of Listing agreement.

Wyeth Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.

Wyeth Limited has informed the Exchange that the Hon'ble High Court of Judicature at Bombay on October 31, 2014, considered and approved the amalgamation of the Company with Pfizer Limited, in terms of the Scheme of Amalgamation between the Company, Wyeth Limited and their respective shareholders and creditors under the provisions of Sections 391 to 394 of the Companies Act, 1956.

Wyeth Limited has informed the Exchange that in terms of SEBI Prohibition of Insider Trading Regulations, 1992 read with the Company's Code of Conduct for Prohibition of Insider Trading ("the Code"), that the Trading Window for trading in the Equity shares of the Company will be closed with effect from October 22, 2014 to November 07, 2014, both days inclusive. Shares of the Company cannot be bought or sold by all designated employees, their spouse and dependent children during this period.

Wyeth Limited has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will remain closed from October 31, 2014 to November 10, 2014 for the purpose of Annual General Meeting of the Company scheduled to be held on November 10, 2014.

Wyeth Limited has informed the Exchange that Mr. Pradip Shah has resigned as Director of the Company with effect from September 30, 2014.

Wyeth Limited has informed the Exchange that pursuant to Section 96 of the Companies Act, 2013 the Company had made an application to the Registrar of Companies, Maharashtra, Mumbai ( RoC ) seeking an extension of time for holding its Annual General Meeting for the financial year ended March 31, 2014. The RoC has granted the Company time up to December 30, 2014 to hold its AGM.

Wyeth Limited has informed the Exchange that Mr. D. E. Udwadia has tendered his resignation as Director of the Company with effect from August 26, 2014. A revised list of Directors is enclosed.

Wyeth Limited has submitted to the Exchange copies of the following: 1. Newspaper advertisements of the Company giving notice of hearing of Petition for approval of the amalgamation of the Company with Pfizer Limited published in the Newspapers on August 07, 2014. 2. Newspaper advertisements of Pfizer Limited giving notice of hearing of Petition for approval of the amalgamation of the Company with Pfizer Limited in the Newspapers on August 07, 2014.

Wyeth Limited has informed the Exchange regarding a press release dated July 25, 2014, titled "Wyeth Ltd's Revenues and Profit from operations for the Quarter up by 16% and 50% respectively"

Wyeth Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2014.

Wyeth Limited has informed the Exchange regarding the "Proceedings of the Court Convened Meetings of Equity Shareholders of Wyeth Limited ("the Company") and Pfizer Limited".

Wyeth Limited has informed the Exchange that the Board of Directors at the meeting held on April 28, 2014, Mr. Darshak Bhagat was appointed as Acting Chief Financial Officer of the Company effective April 1, 2014.

Wyeth Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 28, 2014, has transacted the following:(1) During the year ended March 31, 2014, the Company paid an interim dividend of Rs. 145 per equity share of Rs. 10 each (1450%) aggregating to Rs. 32,944 Lakhs. The Board of Directors of the Company do not recommend any further Dividend.

Wyeth Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2014.

Wyeth Limited has informed the Exchange that the Company had conducted a Postal Ballot seeking approval of the Members to the scheme. The Resolution has been approved by the requisite majority of the Members i.e., the votes cast by the public shareholders (i.e., other than promoter and promoter group shareholders) in favour of the Resolution are more than the number of votes cast by the public shareholders against the Resolution. The company has submitted the details of voting results of the Postal ballot pursuant to Clause 35A of the Listing Agreement. The Scrutinizer's Report will be availa

Wyeth Limited has submitted to the Exchange outcome of Court conveyed meeting held on April 16, 2014.

Wyeth Limited has informed the Exchange regaring the following documents which are being dispatched by the Company and Pfizer Limited to all their respective members: 1. Notices of the Court Convened Meeting of the respective Equity Shareholders of the Company and Pfizer Limited to be held on April 16, 2014.; 2. Notices of postal ballot and e-voting for Equity Shareholders of the Company and Pfizer Limited pursuant to Section 192A of the Companies Act, 1956 read with SEBI Circulars bearing No. CIR/CFD/DIL/5/2013 dated February 4, 2013 and CIR/CFD/DIL/8/2013 dated May 21, 2013; 3. Explanator

Wyeth Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2013.

Wyeth Limited has informed the Exchange that the Trading Window for trading in the Equity shares of the Company is closed from January 11, 2014 to January 28, 2014, both days inclusive. "The company has provided details of trading window period as per Prohibition of Insider Trading Regulations, 1992 issued by SEBI wherein when the trading window is closed, the employees/directors shall not trade in the company s securities in such period".

Wyeth Limited has informed the Exchange regarding press release titled "Pfizer Ltd and Wyeth Ltd to Merge, Creating a Single Pfizer Brand".

Wyeth Limited has informed the Exchange that the Company has fixed Record Date as December 6, 2013 for the purpose of Interim Dividend

Wyeth Limited has informed the Exchange that the Interim Dividend will be paid on December 17, 2013.

Wyeth Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 23, 2013 considered and approved the Scheme of Amalgamation of Wyeth Ltd ("Transferor Company" or "Company") with Pfizer Ltd ("Transferee Company") under the provisions of Sections 391 to 394 and other applicable provisions of the Companies Act, 1956.

Wyeth Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 23, 2013 has approved the payment of Interim Dividend of Rs.145 per equity share of Rs.10 each (1450%) to the shareholders of the Company.

Wyeth Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013.

Wyeth Limited has submitted to the Exchange a copy of the minutes of the Annual General Meeting of the Company held on September 06, 2013.

Wyeth Limited has informed the Exchange that Mr. Pragnesh Shah has resigned as the Acting Chief Financial Officer of the Company with effect from September 11, 2013.

Wyeth Limited has submitted to the Exchange the revised details of the voting results of items placed before the Annual General Meeting (AGM) of Company, held on September 6, 2013.

Wyeth Limited has submitted to the Exchange the details of the Voting Results at the Annual General Meeting of the Members of the Company held on September 06, 2013, under clause 35A of the Listing Agreement.

Wyeth Limited has informed the Exchange that the Government of India on May 15, 2013 notified the Drugs (Prices Control) Order, 2013 bringing into effect a new drug pricing policy applicable to 348 formulations listed in the National List of Essential Medicines (NLEM). The Government has notified the ceiling price for 270 formulations as of now; with the balance notifications expected shortly. Companies have to implement the new price on the 46th day from the date of price notification. This will adversely impact the revenue and profitability of the Company. The above information has been incl

Wyeth Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013.

Wyeth Limited has informed the Exchange that the Company has fixed Book Closure from August 30, 2013 to September 6, 2013 for the purpose of determining the eligibility of payment of dividend. Further the Annual General Meeting of the Company is scheduled to be held on September 06, 2013.

Wyeth Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2013 has Made an additional provision for doubtful debts of Rs. 594 lakhs (quarter ended December 31, 2012 Rs. 550 lakhs and year ended March 31, 2013 Rs. 1144 lakhs) in respect of fraud committed against the Company.

Wyeth Limited has informed the Exchange that the said Dividend, if approved by the shareholders at the Annual General Meeting will be paid on September 12, 2013.

Wyeth Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2013, inter alia, has Recommended a dividend of Rs. 17/- per Equity share of Rs.10 each (170%) on 2,27,20,059 Equity Shares of Rs. 10/- each for the year ended March 31, 2013.

Wyeth Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2013.

The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 03, 2013 to consider and take on record the Audited Financial Results for the quarter, January 1, 2013 to March 31, 2013 and for the year ended March 31, 2013. At the said meeting, the Board of Directors will also consider recommendation of Dividend, if any, for the year ended March 31, 2013. The Company has now informed the Exchange that due to delay in finalization of accounts and completion of audit, the said Board Meeting has been postponed. The new date of the Board Meeting to

Wyeth Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended December 31,2012.

Wyeth Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30, 2012.

Wyeth Limited has submitted to the Exchange a copy of the Minutes of the Annual General Meeting of the Shareholders of the Company held on August 02, 2012.

Wyeth Limited has informed the Exchange regarding details of Voting Results placed at the Annual General Meeting of the Company held on August 02, 2012 pursuant to clause 35A of Listing Agreement.

Wyeth Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2012.

Wyeth Limited had informed the Exchange regarding Book Closure from July 10, 2012 to July 23, 2012 (both days inclusive) to determine the Members entitled to dividend. The Annual General Meeting is scheduled to be held on July 23, 2012. The Company has now informed the Exchange the Board at its Meeting held on June 28, 2012 has re-scheduled the date of the Annual General Meeting of the Company from July 23, 2012 to August 02, 2012. Further, the Company has inform that the Register of Members & Share Transfer Books of the Company will remain closed from July 20, 2012 to August 02, 2012 (both d

Wyeth Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on June 28, 2012 the following Matters were noted/ decision were taken: 1) Mr. Aijaz Tobaccowalla was appointed as an Additional Director effective June 28, 2012. 2) The Board noted the resignation of Mr. Kewal Handa as Managing Director and Director of the Company with effect from end of day August 15, 2012. 3) Mr. Aijaz Tobaccowalla was appointed Managing Director of the Company effective commencement of business August 16, 2012, subject to the approval of the shareholders at the ensuing An

Wyeth Limited has informed the Exchange that the Register of Members of the Company will be closed from July 10, 2012 to July 23, 2012 (both days inclusive) to determine the Members entitled to dividend. The Annual General Meeting is scheduled to be held on July 23, 2012.